Research Article

Utilizing Network Pharmacology and Molecular Docking Integrated Surface Plasmon Resonance Technology to Investigate the Potential Targets and Mechanisms of Tripterygium wilfordii against Pulmonary Artery Hypertension

Table 1

The main components of Tripterygium wilfordii.

Molecule IDCompound nameOBDLHdonHacc

MOL000296Hederagenin36.910.7511
MOL003182(+)-Medioresinol di-O-beta-D-glucopyranoside_qt60.690.6227
MOL00318481827-74-945.420.5314
MOL003185(1R,4aR,10aS)-5-Hydroxy-1-(hydroxymethyl)-7-isopropyl-8-methoxy-1,4a-dimethyl-4,9,10,10a-tetrahydro-3H-phenanthren-2-one48.840.3824
MOL003187Triptolide51.290.6816
MOL003188Tripchlorolide78.720.7226
MOL003189Wilforlide A35.660.7224
MOL003192Triptonide67.660.706
MOL003196Tryptophenolide48.50.4413
MOL0031995,8-Dihydroxy-7-(4-hydroxy-5-methyl-coumarin-3)-coumarin61.850.5437
MOL003206Canin77.410.3315
MOL003208Celafurine72.940.4426
MOL003209Celallocinnine83.470.5925
MOL003211Celaxanthin47.370.5811
MOL003217Isoxanthohumol56.810.3925
MOL003225Hypodiolide A76.130.4913
MOL003229B Triptinin B34.730.3223
MOL003231Triptoditerpenic acid B40.020.3613
MOL003232Triptofordin B139.550.8416
MOL003244Triptonide68.450.6806
MOL003245Triptonoditerpenic acid42.560.3924
MOL003248Triptonoterpene48.570.2812
MOL00326621-Hydroxy-30-norhopan-22-one34.110.7712
MOL003278Salaspermic acid32.190.6324
MOL003280TRIPTONOLIDE49.510.4914
MOL000358Beta-sitosterol36.910.7511
MOL000211Mairin55.380.7823
MOL000422Kaempferol41.880.2446
MOL000449Stigmasterol43.830.7611
MOL00205840957-99-157.20.6227
MOL004443Zhebeiresinol58.720.1916
MOL005828Nobiletin61.670.5208
MOL007415[(2S)-2-[[(2S)-2-(Benzoylamino)-3-phenylpropanoyl]amino]-3-phenylpropyl] acetate58.020.5226
MOL007535(5S,8S,9S,10R,13R,14S,17R)-17-[(1R,4R)-4-Ethyl-1,5-dimethylhexyl]-10,13-dimethyl-2,4,5,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6-dione33.120.7902
MOL0093863,3′-Bis-(3,4-dihydro-4-hydroxy-6-methoxy)-2H-1-benzopyran52.110.5426
MOL011169Peroxyergosterol44.390.8213